Rna Interference Drug Delivery Market Size And Share

  • Report Code : TIPRE00021846
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Dimensioni, segmenti e analisi del mercato della somministrazione di farmaci tramite interferenza dell'RNA entro il 2025-2031

Buy Now

RNA Interference Drug Delivery Market Report RNA Interference Drug Delivery Market Scope and Analysis RNA Interference Drug Delivery Market Size and Share

RNA Interference Drug Delivery Market Report Analysis

RNA Interference Drug Delivery Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Tekmira Pharmaceuticals Corp.
  • Alnylam Pharmaceuticals Inc.
  • Merck
  • Isis Pharmaceuticals, Inc
  • Access Pharmaceuticals Inc.
  • Dicerna Pharmaceuticals Inc.
  • Calondo Pharmaceuticals Inc.
  • Marina Biotech Inc.
  • RXi Pharmaceuticals Corp.

Regional Overview

  • Nord America
  • Europa
  • Asia-Pacifico
  • America centrale e meridionale
  • Medio Oriente e Africa

Market Segmentation

By Tipo di intervento chirurgico
  • tecnologia di somministrazione di farmaci con nanoparticelle
  • tecnologia di somministrazione di farmaci per via polmonare
  • tecnologia di somministrazione di farmaci con acido nucleico
  • tecnologia di somministrazione di farmaci con aptameri
By Applicazioni
  • Malattie infettive
  • Cardiologia
  • Oncologia
  • Neurologia
  • Oftalmologia
  • Disturbi metabolici
By Geografia
  • America del Nord
  • Europa
  • Asia-Pacifico
  • America centrale e meridionale